Table 1. Characteristics of facilities and patients in the study of quality of HIV care at health facilities in the Eastern and Nyanza regions of Kenya, January 2014 to March 2016 .
| Characteristic |
No. (%) of facilities (n = 63) |
No. (%) of patients enrolled (n = 13 331) |
|---|---|---|
| Facility characteristics | ||
| Facility type | ||
| Public primary | 33 (52) | 5 856 (44) |
| Public secondary | 24 (38) | 6 662 (50) |
| Privatea | 6 (10) | 813 (6) |
| Facility location | ||
| Urban | 1 (2) | 650 (5) |
| Semi-urban | 27 (43) | 6 824 (51) |
| Rural | 35 (56) | 5 857 (44) |
| Region | ||
| Eastern | 16 (25) | 3 636 (27) |
| Nyanza | 47 (75) | 9 695 (73) |
| CD4+ cell testing | ||
| Specimen collected & analysed at facility | 18 (29) | 5 661 (42) |
| Specimen collected at facility, analysed elsewhere | 45 (71) | 7 670 (58) |
| Community ART adherence group | ||
| Yes | 32 (51) | 6 871 (52) |
| No | 31 (49) | 6 460 (48) |
| Financial incentives for adherence | ||
| Yes | 5 (8) | 1 346 (10) |
| No | 58 (92) | 11 985 (90) |
| Facility-based adherence support, group counselling | ||
| Yes | 61 (97) | 13 038 (98) |
| No | 2 (3) | 293 (2) |
| Assessment of ART eligibility by nurseb | ||
| Yes | 56 (89) | 11 996 (90) |
| No | 7 (11) | 1 335 (10) |
| Initiation of ART by nurseb | ||
| Yes | 54 (86) | 11 092 (83) |
| No | 9 (14) | 2 239 (17) |
| Follow-up of ART by nurseb | ||
| Yes | 53 (84) | 10 738 (81) |
| No | 10 (16) | 2 593 (19) |
| Physician at HIV clinicc | ||
| Yes | 5 (8) | 1 436 (11) |
| No | 58 (92) | 11 895 (89) |
| Outreach workers at HIV clinic | ||
| Yes | 29 (46) | 6 496 (49) |
| No | 34 (54) | 6 835 (51) |
| Patient volume, no. of new enrollees per year | ||
| < 150 | 24 (38) | 2 358 (18) |
| 150–300 | 29 (46) | 6 283 (47) |
| > 300 | 10 (16) | 4 690 (35) |
| Patient characteristics at enrolment | ||
| Median (IQR) age, years | N/A | 30.2 (23.7–38.5) |
| Age, years | ||
| < 2 | N/A | 415 (3) |
| 2–14 | N/A | 836 (6) |
| 15–24 | N/A | 2 652 (20) |
| 25–39 | N/A | 6 530 (49) |
| 40–49 | N/A | 1 727 (13) |
| 50+ | N/A | 1 171 (9) |
| Sex | ||
| Male | N/A | 4 728 (35) |
| Female | N/A | 8 603 (65) |
| Immune status at enrolment | ||
| CD4+ cell count > 200 cells/µL, or WHO stage 1 or 2 | N/A | 7 847 (59) |
| CD4+ cell count ≤ 200 cells/µL, or WHO stage 3 or 4 | N/A | 3 612 (27) |
| Unrecorded | N/A | 1 872 (14) |
ART: antiretroviral therapy; CD4+ cell: CD4+ T lymphocyte; HIV: human immunodeficiency virus; IQR: interquartile range; N/A: not applicable; WHO: World Health Organization.
a Private-sector facilities are not formally categorized into primary or secondary by the government of Kenya. Health centres listed as private were mostly faith-based health centres offering limited services similar to primary-care centres.
b Nurse-led care included care by clinical officers (non-physician clinicians).
c Facilities with physician-led care also provided care by nurses or clinical officers.
Notes: n is the total number of facilities or total number of patients enrolled at those facilities. Data were collected for patients enrolling in HIV care between January 2014 and March 2015 and followed up to 31 March 2016.